June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
IL-23 drives uveitis by acting on a novel population of resident ocular T cells
Author Affiliations & Notes
  • David Copland
    Translational Health Sciences, University of Bristol, Bristol, Bristol, United Kingdom
    Institute of Ophthalmology, University College London, London, London, United Kingdom
  • Robert Hedley
    Sir William Dunn School of Pathology, University of Oxford, Oxford, Oxfordshire, United Kingdom
  • Amy Ward
    Translational Health Sciences, University of Bristol, Bristol, Bristol, United Kingdom
  • Colin Chu
    Institute of Ophthalmology, University College London, London, London, United Kingdom
    Translational Health Sciences, University of Bristol, Bristol, Bristol, United Kingdom
  • Jonathan Sherlock
    Kennedy Institute of Rheumatology, University of Oxford, Oxford, Oxfordshire, United Kingdom
    Janssen Global Services LLC, Palo Alto, California, United States
  • Andrew D Dick
    Translational Health Sciences, University of Bristol, Bristol, Bristol, United Kingdom
    Institute of Ophthalmology, University College London, London, London, United Kingdom
  • Footnotes
    Commercial Relationships   David Copland None; Robert Hedley None; Amy Ward None; Colin Chu None; Jonathan Sherlock Janssen, Code E (Employment); Andrew Dick None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 2864. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      David Copland, Robert Hedley, Amy Ward, Colin Chu, Jonathan Sherlock, Andrew D Dick; IL-23 drives uveitis by acting on a novel population of resident ocular T cells. Invest. Ophthalmol. Vis. Sci. 2023;64(8):2864.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Acute anterior uveitis is a frequent ocular co-morbidity strongly associated with the Spondyloarthropathies (SpA), a group of chronic inflammatory diseases affecting the joints, skin, and gut of patients. Pathology at these different anatomical sites is driven by local resident populations of interleukin (IL)-23 responsive lymphoid cells. We therefore sought evidence for a resident population of IL-23 responsive cells within the ocular entheseal tissues.

Methods : B6(Cg)-Tyrc-2J/J (albino) and C57BL/6J IL-23R-eGFP reporter mice were used to determine tissue localization and phenotype of resident CD3+ populations in normal mouse anterior uvea. Perfused eyes were optically cleared for whole tissue Ce3D Lightsheet imaging. Flow cytometry (FACS) and ImageStream®X MK II analysis was performed to immunophenotype cells. To evaluate IL-23 responsiveness, C57BL/6J or Rag2-/- mice received intravitreal (IVT) injection of ShH10 adeno-associated virus (AAV) encoding an IL-23 hyperkine. Clinical assessment (Fundus & OCT) was performed to determine onset of clinical inflammation. Dissected anterior and posterior uvea were processed for FACS enumeration of CD45+ infiltrate.

Results : Ex vivo tissue imaging of naïve eyes reveals CD3+IL-23R+ cells are located across multiple tissues of the anterior uvea, including the sclera, iris, and ciliary body. FACS identifies 50-100 cells/eye, and defines the naive phenotype as CD3+CD4-CD8-TCRγδ+RORγt+IL-23R+. In vivo, IL-23 over-expression elicits clinical inflammation in anterior and posterior segments of the eye by day 12. FACS confirms a significant increase in CD45+CD3+ cell number in anterior and posterior compared to eyes receiving control ShH10 vector. Ex vivo stimulation of anterior uvea shows increased IL-17A production by CD3+γδTCR+ from cells following IL-23 overexpression. ShH10-mediated IL-23 expression does not elicit clinical inflammation or infiltration of CD45+ cells in Rag2 deficient mice.

Conclusions : A novel population of ocular T cells defined by CD3+CD4-CD8-γδTCR+IL-23R+ expression resides within the anterior uvea of the mouse eye. Localised ocular cytokine expression demonstrates that resident IL-23R+ IL-17A producing cells are both necessary and sufficient to drive uveitis in response to IL-23. Further characterization of this population is warranted.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×